Related Experiment Video
Updated: Aug 5, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
Peptide Loading Complex in Cancer: From Peptide Translocation, Editing, and Loading into MHC-I to a Potential
Omer Qutaiba B Allela1, Abdulkareem Shareef2, Hayder Naji Sameer3
1College of Pharmacy, Alnoor University, Mosul, Iraq. omerallela@alnoor.edu.iq.
Current Medical Science
|July 27, 2026
Summary
The peptide-loading complex (PLC) is crucial for cancer cells to evade immune detection. Targeting PLC dysfunction offers a promising strategy to enhance anti-tumor immunity and overcome treatment resistance.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- The peptide-loading complex (PLC) in the endoplasmic reticulum is essential for presenting antigens via MHC-I molecules to CD8+ T cells.
- Cancer cells often exhibit impaired PLC function, leading to reduced MHC-I expression and immune evasion.
- Malignancies can exploit PLC defects for tumor progression and resistance to therapy.
Purpose of the Study:
- To provide an overview of the PLC's role in tumor immune escape.
- To highlight PLC as a potential therapeutic target in cancer treatment.
- To discuss emerging strategies for restoring PLC function.
Main Methods:
- Literature review and synthesis of current research on PLC in cancer.
- Analysis of molecular mechanisms underlying PLC dysfunction in tumorigenesis.
- Exploration of therapeutic interventions targeting PLC components and pathways.
Main Results:
- PLC malfunctions are implicated in impaired antigen presentation and immune escape.
- Individual PLC components influence tumor development, progression, and treatment resistance.
- Therapeutic strategies targeting PLC are being developed to enhance anti-tumor immunity.
Conclusions:
- The peptide-loading complex is a critical determinant of tumor immune escape.
- Restoring or reprogramming PLC function presents a viable therapeutic avenue for cancer treatment.
- Targeting PLC may overcome immune evasion and improve treatment outcomes in oncology.
Related Concept Videos
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:28Protein Translocation Machinery on the ER Membrane
The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
01:27Post-translational Translocation of Proteins to the RER
A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
01:20Cotranslational Protein Translocation
Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...